Company performance
Add to research
Current Price
as of Feb 07, 2025$1.59
P/E Ratio
N/A
Market Cap
$449.54M
Description
Add to research
Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerERAS
- Price$1.59-4.79%
Trading Information
- Market cap$449.54M
- Float57.80%
- Average Daily Volume (1m)1,442,287
- Average Daily Volume (3m)1,365,089
- EPS-$0.83
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$31.20M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$36.40M
- EV$504.94M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.00
- Debt/Equity11.76
Documents
Add to research
SEC Filings